Stay updated on AFM13-NK vs AFM13 in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the AFM13-NK vs AFM13 in Lymphoma Clinical Trial page.

Latest updates to the AFM13-NK vs AFM13 in Lymphoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page shows an updated interface/release revision, changing the displayed version from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check22 days agoChange DetectedAdded a new publication citation (Nat Med 2025) for Allogeneic NK cells with AFM13-NK and AFM13, including the erratum. Updated the revision to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.5.0 was added to the site revisions. The v3.4.3 entry was removed.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2 version.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page shows a small update to site versioning with Revision: v3.4.2, replacing Revision: v3.4.1, which does not change the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check94 days agoChange DetectedAdded a site-wide notice about potential delays due to a lapse in government funding and updated the site revision to v3.4.1. The revision v3.4.0 was removed.SummaryDifference0.4%

Stay in the know with updates to AFM13-NK vs AFM13 in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFM13-NK vs AFM13 in Lymphoma Clinical Trial page.